|
|
|
|
LEADER |
00916nam a2200289Ia 4500 |
001 |
10-1016-j-jaip-2021-12-015 |
008 |
220420s2022 CNT 000 0 und d |
020 |
|
|
|a 22132198 (ISSN)
|
245 |
1 |
0 |
|a Key Issues in Pediatric and Adult Severe Asthma: Staying Grounded as Biologics Take Us to New Heights
|
260 |
|
0 |
|b American Academy of Allergy, Asthma and Immunology
|c 2022
|
300 |
|
|
|a 2
|
856 |
|
|
|z View Fulltext in Publisher
|u https://doi.org/10.1016/j.jaip.2021.12.015
|
650 |
0 |
4 |
|a adult
|
650 |
0 |
4 |
|a Adult
|
650 |
0 |
4 |
|a antiasthmatic agent
|
650 |
0 |
4 |
|a Anti-Asthmatic Agents
|
650 |
0 |
4 |
|a asthma
|
650 |
0 |
4 |
|a Asthma
|
650 |
0 |
4 |
|a biological product
|
650 |
0 |
4 |
|a Biological Products
|
650 |
0 |
4 |
|a child
|
650 |
0 |
4 |
|a Child
|
650 |
0 |
4 |
|a human
|
650 |
0 |
4 |
|a Humans
|
700 |
1 |
0 |
|a Guilbert, T.W.
|e author
|
700 |
1 |
0 |
|a Israel, E.
|e author
|
773 |
|
|
|t Journal of Allergy and Clinical Immunology: In Practice
|